Science Explorer Back to mapMap
Discussion
Researcher · Evotec (Germany) · Germany

Klaus Godl

Klaus Godl publishes mostly in Molecular Biology, Oncology and Hematology, on topics such as Protein Kinase Regulation and GTPase Signaling, Melanoma and MAPK Pathways and Protein Degradation and Inhibitors.

OpenAlex
World rank
#2,317,365
of 7,710,434 ranked researchers
Rank in Germany
#114,467
of 364,343
Works
44
Citations
1.9k
Citations per work
42.5
h-index
22
i10-index 24Top 28% in Molecular Biology
Klaus Godl

What does Klaus Godl research?

Klaus Godl's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Medicine (22%), Chemistry (6%).

Everything else: 16 works · 36.3% of their workLife Sciences: 15 works · 33.0% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 33.0% of their workMolecular Biology: 15 works · 33.0% of their workHealth Sciences: 10 works · 21.6% of their workMedicine: 10 works · 21.6% of their workHematology: 4 works · 9.1% of their workOncology: 4 works · 9.1% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 3.4% of their workPhysical Sciences: 4 works · 9.1% of their workChemistry: 3 works · 5.7% of their workSpectroscopy: 3 works · 5.7% of their workMaterials Science: 1 works · 3.4% of their workBiomaterials: 1 works · 3.4% of their workTHEIR WORKKlaus Godl44works
Life Sciences33%Physical Sciences9%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1636.3%
    1. Biochemistry, Genetics and Molecular Biology1533.0%
    1. Medicine1021.6%
    1. Chemistry35.7%
    2. Materials Science13.4%
  1. 1Molecular Biology33% of their works
  2. 2Oncology9% of their works
  3. 3Hematology9% of their works
  4. 4Spectroscopy6% of their works
  5. 5Biomaterials3% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Klaus Godl's research?

The keywords of their largest research topics: Cancer Therapy, Oncogenic Mutations, Acute Myeloid Leukemia, AML, BET Bromodomains, BRAF gene, MAP Kinase and Mass Spectrometry.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy82 topics
  2. Oncogenic Mutations82 topics
  3. AML41 topic
  4. Acute Myeloid Leukemia41 topic
  5. BET Bromodomains41 topic
  6. BRAF gene41 topic
  7. MAP Kinase41 topic
  8. Mass Spectrometry41 topic
  9. PROTACs41 topic
  10. Protein Kinases41 topic
  11. Proteomics41 topic
  12. Ras Signaling41 topic
  13. Eukaryotic Microbes31 topic
  14. Fc Receptors31 topic
  15. Microbial Diversity31 topic
  16. Therapeutic Antibodies31 topic
  17. Fatty Acid Synthase21 topic
  18. Lipid Metabolism21 topic

Where does Klaus Godl work?

Klaus Godl's main affiliation in the publication record is Evotec (Germany), Germany.

How many publications and citations does Klaus Godl have?

OpenAlex counts 44 works and 1,872 citations for Klaus Godl, an h-index of 22, ranking #2,317,365 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Klaus Godl. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.